title: What can we learn from the ZOOM trial?
authors.affiliation: Swiss Group for Clinical Cancer Research, Bern, Switzerland. Electronic address: stefanie.hayoz@sakk.ch.
authors.forename: Stefanie
authors.initials: S
authors.lastname: Hayoz
authors.forename: Dirk
authors.initials: D
authors.lastname: Klingbiel
authors.forename: Peter
authors.initials: P
authors.lastname: Brauchli
authors.forename: Roger von
authors.initials: Rv
authors.lastname: Moos
mesh_terms: D050071:Bone Density Conservation Agents / Q000627:therapeutic use*; D001859:Bone Neoplasms / Q000188:drug therapy*; D001943:Breast Neoplasms / Q000188:drug therapy*; D004164:Diphosphonates / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007093:Imidazoles / Q000627:therapeutic use*
chemical_list: D050071:Bone Density Conservation Agents; D004164:Diphosphonates; D007093:Imidazoles